Milestone Pharmaceuticals Inc. · NASDAQ:MIST

Trails Edge Capital Partners, LP reported a 9.90% stake in Milestone Pharmaceuticals Inc. (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

Trails Edge Capital Partners, LP reported a 9.90% stake in Milestone Pharmaceuticals Inc., 9,017,880 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
9.90%
Shares
9,017,880
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
Trails Edge Capital Partners, LP9.90%9,017,880
Trails Edge Biotechnology Master Fund, LP9.90%9,017,880
Ortav Yehudai9.90%9,017,880

Source

View original at SEC

Related